(NEW YORK) -- Pfizer announced Wednesday it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children. The treatment, Paxlovid, was authorized in December 2020 by the U.S. Food and Drug Administration for emergency use in patients aged... Read More.
(WASHINGTON) -- Moderna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants... Read More.
(NEW YORK) -- The American Academy of Clinical Neuropsychologists (AACN), the professional organization that sets standards and practices for the field of neuropsychology, has called for "the elimination of race as a variable in demographically-based normative test interpretation," the controversial practice widely known as... Read More.
(NEW YORK) -- Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesday. Based on safety, efficacy and tolerability data from Pfizer's Phase 1 trial, the company will use 10 micrograms of each... Read More.